IL-27 has been thoroughly investigated in several autoimmune disorders, such as inflammatory bowel disease, rheumatoid arthritis (RA), experimental autoimmune encephalitis (EAE), psoriasis, and Sjögren’s syndrome (SS) [23–27]. Here, IL27 is linked to synovial sarcoma.